Your browser doesn't support javascript.
loading
Optimizing Disclosure of HIV Status to a Diverse Population of HIV-Positive Youth at an Urban Pediatric HIV Clinic.
Dantuluri, Keerti L; Carlucci, James G; Howard, Leigh M; Johnson, David P; Spencer, Hillary; Desai, Neerav A; Garguilo, Kathryn A; Wilson, Gregory J.
Afiliación
  • Dantuluri KL; Department of Pediatrics (Infectious Diseases), Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: keerti.dantuluri@atriumhealth.org.
  • Carlucci JG; Department of Pediatrics (Infectious Diseases), Vanderbilt University Medical Center, Nashville, Tennessee.
  • Howard LM; Department of Pediatrics (Infectious Diseases), Vanderbilt University Medical Center, Nashville, Tennessee.
  • Johnson DP; Department of Pediatrics (Hospital Medicine), Vanderbilt University Medical Center, Nashville, Tennessee.
  • Spencer H; Department of Pediatrics (Infectious Diseases), Vanderbilt University Medical Center, Nashville, Tennessee.
  • Desai NA; Department of Pediatrics (Adolescent and Young Adult Health), Vanderbilt University Medical Center, Nashville, Tennessee.
  • Garguilo KA; Department of Pediatrics (Infectious Diseases), Vanderbilt University Medical Center, Nashville, Tennessee.
  • Wilson GJ; Department of Pediatrics (Infectious Diseases), Vanderbilt University Medical Center, Nashville, Tennessee.
J Adolesc Health ; 68(4): 713-718, 2021 04.
Article en En | MEDLINE | ID: mdl-33187819
ABSTRACT

PURPOSE:

The purpose of the study was to increase the proportion of youth living with HIV (YLWH) aged ≥11 years who undergo developmentally appropriate disclosure about their HIV status.

METHODS:

A quality improvement project was initiated at an urban pediatric HIV clinic between July 2018 and March 2020. The primary outcome measure was the proportion of YLWH aged ≥11 years who were disclosed to about their HIV status. The proportion of undisclosed YLWH who had documented nondisclosure status was also assessed as a process measure. Plan-Do-Study-Act (PDSA) cycles for change included monthly clinic staff check-ins to discuss new disclosures, quarterly team meetings to discuss strategies to improve disclosure, and modifying a clinic note template to prompt providers to document disclosure status. Annotated run charts were used to analyze the data.

RESULTS:

Before the first PDSA cycle, 26/46 (57%) of the target population of YLWH aged ≥11 years had their HIV status disclosed to them, and none of the undisclosed youth had disclosure status documented in their medical record. After 20 months and six PDSA cycles, the proportion of YLWH aged ≥11 years disclosed to about their HIV status increased to 80% and the proportion of undisclosed YLWH with documentation of their disclosure status increased to 100%.

CONCLUSIONS:

Several interventions integrated throughout the pediatric HIV care process were associated with an increase in the proportion of YLWH with developmentally appropriate HIV disclosure and documentation of disclosure status, an important psychosocial aspect of care in these individuals.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Revelación Límite: Adolescent / Child / Humans Idioma: En Revista: J Adolesc Health Asunto de la revista: PEDIATRIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Revelación Límite: Adolescent / Child / Humans Idioma: En Revista: J Adolesc Health Asunto de la revista: PEDIATRIA Año: 2021 Tipo del documento: Article